This compound is a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and an oxazolidine ring. It is primarily used as a building block in solid-phase peptide synthesis, enabling the incorporation of sterically hindered amino acid residues.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1266350-99-5
Fmoc-Asp(Otbu)-Thr(Psime,Mepro)-OH
pharmaceutical intermediate
Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH
research compound
4-Oxazolidinecarboxylic acid, 3-((2S)-2-(((9H-fluoren-9-ylmethoxy)carbonyl)amino)-1-oxo-3-phenylpropyl)-2,2,5-trimethyl-, (4S,5R)-
pharmaceutical intermediate
Fmoc-Glu(OtBu)-Thr(psi(Me,Me)pro)-OH
research compound
Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH
research compound
Fmoc-Pro-Pro-OH
research compound
N-[(tert-Butoxy)carbonyl]-L-tryptophan
research compound
Fmoc-L-glutamic acid 5-allyl ester
research compound
(4S,5R)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]propanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid
AVAILEBHPYBEGO-CQLNOVPUSA-N
C[C@@H]1[C@H](N(C(O1)(C)C)C(=O)[C@H](COC(C)(C)C)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
—